Market Tracker

08/21 5:16pm ET

Heron Therapeutics Inc (NASDAQ:HRTX)

15.40
Delayed Data
As of 3:59pm ET
 +0.15 / +0.98%
Today’s Change
12.21
Today|||52-Week Range
21.24
+17.56%
Year-to-Date

Today’s Trading

Previous close15.25
Today’s open15.25
Day’s range14.90 - 15.40
Volume363,839
Average volume (3 months)785,184
Market cap$825.6M
Dividend yield--
Data as of 3:59pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)-54.76%
Earnings growth (this year)+22.54%
Earnings growth (next 5 years)+44.06%
Revenue growth (last year)--
P/E ratioNM
Price/Sales388.44
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EGRXEagle Pharmaceutical...-0.16-0.30%
SPPISpectrum Pharmaceuti...-0.03-0.32%
ADROAduro Biotech Inc+0.05+0.47%
ATNXAthenex Inc+0.80+5.26%
Data as of 4:00pm ET, 08/21/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$1.3M
Annual profit (last year)-$173.1M
Net profit margin-13,537.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts